Check out this study on the benefits of conduction system pacing in patients with symptomatic first-degree AV block.
onlinelibrary.wiley.com/doi/…
👬 AV block 1, mean PR 395 ms, preserved EF
✅ Improved symptoms, ⬆ stroke volume by 10%
❗ Look for mechanical AV dyssynchrony; use CSP
Anja Zupan Mežnar retweeted
#EHRAchat Q3: Preventive-VT trial at #EHRA2024 showed that preventive VT ablation in ptswith ICD, ischemic cardiomyopathy and infarct-related coronary CTO lowers the rates of appropriate ICD activations. Why is this important? @SergeBoveda @AndreaSarkozy
Anja Zupan Mežnar retweeted
Impact of preventive substrate #catheter #ablation on implantable #cardioverter-defibrillator interventions in pts w/ #ischaemic #cardiomyopathy & #infarct-related #coronary chronic total occlusion-PREVENTIVE VT trial-visual summary #EHRA2024 #EHRA_ESC
@SergeBoveda @EmmaSvennberg
Anja Zupan Mežnar retweeted
Anja Zupan Mežnar retweeted
🔥HOTLINE 7
DANPACE II randomized trial
👉 539 SND pts followed with remote monitoring (45%history of AF)
👉DDD-40 vs DDDR-60:
⬇️ Atrial pacing
🟰#Afib at fup
⬆️Syncope/presyncope
#ESCCongress #Epeeps #EHRA
@KronborgMB @joselmerino @LindeCecilia
Anja Zupan Mežnar retweeted
Breaking news #ESCCongress - FRAIL AF TRIAL: Switching VKA to NOAC in frail elderly AF pnts ⬆️ bleeding complications
@VDelgadoGarcia @Drroxmehran
@mirvatalasnag @DavidDuncker
@CMichaelGibson @alaide_chief
@HanCardiomd @jozinetm
@mewton_nathan @m4ggiesimpson
@ARakisheva
Anja Zupan Mežnar retweeted
Breaking news #ESCCongress - BUDAPEST TRIAL: CRT-D upgrade ⬇️ morb + mortal + ⬆️ LV remod in HFrEF with RV pacing
@VDelgadoGarcia @Drroxmehran
@mirvatalasnag @DavidDuncker
@CMichaelGibson @alaide_chief
@HanCardiomd @jozinetm
@mewton_nathan @m4ggiesimpson
@ARakisheva
Anja Zupan Mežnar retweeted
New findings from the #BUDAPEST CRT Upgrade study:
In #HFrEF patients with high RV pacing burden & wide paced QRS, upgrading to CRT-D vs. ICD-only significantly reduced #HeartFailure hospitalizations, deaths, and lack of reverse remodeling.
#ESCCongress @WilfriedMullens @ARakisheva @mvaduganathan @AndrewJSauer @DrMarthaGulati
Anja Zupan Mežnar retweeted
BREAKING NEWS #ESCCongress NOAH-AFNET 6 trial; NOAC for atrial high rate episodes ⬆️ bleeds but NO ⬇️ stroke, emboli, CVdeath
@VDelgadoGarcia @Drroxmehran @mirvatalasnag @DavidDuncker @CMichaelGibson @alaide_chief @HanCardiomd @jozinetm @mewton_nathan @m4ggiesimpson @ARakisheva
Anja Zupan Mežnar retweeted
BREAKING NEWS #ESCCongress OPT-PACE trial ⬇️ HFH/mortality via TTE-guided screening of PM pnts in HF units.
@VDelgadoGarcia @Drroxmehran @mirvatalasnag @DavidDuncker @CMichaelGibson @alaide_chief @HanCardiomd @jozinetm @mewton_nathan @m4ggiesimpson @ARakisheva @KlausKWitte
Anja Zupan Mežnar retweeted
New @escardio guidelines on cardiomyopathies
Extensive first time guideline!
Congratulations @arbelo_e and team!
academic.oup.com/eurheartj/a…
#ESCCongress
Great privilege to discuss pacing and EP in heart failure with @WilfriedMullens and @cleclercqrennes at #HFASnacks during #HeartFailure2023
@BorAntolic
.@azm99 & @cleclercqrennes give you all the updates on EP that you need to know! hosted by @WilfriedMullens
Watch their #HFASnacks 🤗
#HFA_ESC #HeartFailure2023
#HFASnacks at #HeartFailure2023
Anja Zupan Mežnar retweeted
🔴 2023 HRS/APHRS/LAHRS guideline on cardiac physiologic pacing for the avoidance and mitigation of heart failure @hrs_journal #CardioEd #Cardiology #EPeeps #CardioTwitter @LAHRSonline1 @APHRSOfficial @HRSonline



































